EGM
SRNE

Engineers Gate Manager’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Engineers Gate Manager’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-93,433
Closed -$82.8K – 2130
2022
Q4 		$82.8K Buy
93,433
+15,823
+20% +$21K 0.01% 1511
2022
Q3 		$122K Sell
77,610
-70,123
-47% -$159K 0.01% 1418
2022
Q2 		$297K Buy
147,733
+41,854
+40% +$72.4K 0.01% 1428
2022
Q1 		$247K Buy
105,879
+78,316
+284% +$244K 0.01% 1517
2021
Q4 		$128K Buy
+27,563
New +$171K 0.01% 1775
2021
Q2 		– Sell
-63,100
Closed -$522K – 2156
2021
Q1 		$522K Sell
63,100
-9,500
-13% -$100K 0.03% 969
2020
Q4 		$495K Buy
+72,600
New +$583K 0.02% 997

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Engineers Gate Manager's SRNE Position: Q1 2023 in Review

Engineers Gate Manager sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 93,433 shares — an estimated $82.8K sold.

Engineers Gate Manager first reported a position in SRNE in Q4 2020 and held it in 7 quarters. The position peaked at $522K in Q1 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Engineers Gate Manager reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Engineers Gate Manager sold 93,433 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $82.8K.
  • Engineers Gate Manager first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 7 quarters.
  • Engineers Gate Manager's Sorrento Therapeutics, Inc. position peaked at $522K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Engineers Gate Manager's 13F filing for Q1 2023, filed 15 May 2023.